Presence of copy number aberration and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification.
Acute myeloid leukemia (AML) is characterized by multiple acquired genetic events, chromosomal abnormalities like copy number aberrations (CNAs), disease progression and low survival rate. of the study were to assess the utility of the Multiplex Ligation-dependent Probe Amplification (MLPA) assays in AML and to correlate CNAs with various biological and clinical features of AML patients, such as somatic mutations in FLT3, NPM1, DNMT3A genes and survival. The present study included 283 AML patients. MLPA was used for investigation of CNAs. Somatic mutations' status was analyzed in all cases. The presence of CNAs was associated with European LeukemiaNet (ELN) high-risk (pFDR<0.0001). The presence of CNAs was not a significant predictor of death, while the significant predictors of mortality were: age ≥65 years (HR = 2.30, 95% CI: 1.71-3.09), ELN high-risk (HR = 1.71, 95% CI: 1.15-2.56) and Eastern Cooperative Oncologic Group Scale (ECOG) performance status ≥3 (HR = 2.43, 95% CI: 1.80-3.30). We showed that CNAs significantly interact with ECOG status, HRinteraction = 2.24 (95% CI: 1.09-4.57), p = 0.02, which means that the presence of CNAs was positively associated with risk of death in cases with ECOG status ≥3 (HR = 2.02, 95% CI: 1.30-3.12) while for patients with ECOG performance status grade ≤2 the presence of CNAs was a protective factor for risk of death. AML cases with CNAs and ECOG performance status ≥3 had an increased risk of death and the presence of CNAs may modify the effect of ECOG performance status on survival. Independent predictors for mortality in AML are represented by age group, high-risk ELN and ECOG status ≥3.